Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 481 AL 495

Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes

Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova C.

Drugs Aging. 2012 Oct;29(10):793-806. doi: 10.1007/s40266-012-0012-5.

Estrogens and Alzheimer disease risk: is there a window of opportunity?

Henderson VW, Rocca WA.

Neurology. 2012 Oct 30;79(18):1840-1. doi: 10.1212/WNL.0b013e318271f88f. Epub 2012 Oct 24.

Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study

van Vliet D, de Vugt ME, Aalten P, Bakker C, Pijnenburg YA, Vernooij-Dassen MJ, Koopmans RT, Verhey FR.

Dement Geriatr Cogn Disord. 2012;34(5-6):319-27. doi: 10.1159/000342824. Epub 2012 Dec 3.

Adult polyglucosan body disease masquerading as "ALS with dementia of the Alzheimer type": an exceptional phenotype in a rare pathology

Segers K, Kadhim H, Colson C, Duttmann R, Glibert G.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):96-9. doi: 10.1097/WAD.0b013e31821cc65d.

Greater responsiveness to donepezil in Alzheimer patients with higher levels of acetylcholinesterase based on attention task scores and a donepezil PET study

Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):113-8. doi: 10.1097/WAD.0b013e3182222bc0.

Anomalous PiB enhancement in the superior sagittal and transverse venous sinuses

Raymond SB, Cohen AD, Becker C, Price J, Klunk WE.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):186-90. doi: 10.1097/WAD.0b013e31822de18c.

Memantine and functional communication in Alzheimer's disease: results of a 12-week, international, randomized clinical trial

Saxton J, Hofbauer RK, Woodward M, Gilchrist NL, Potocnik F, Hsu HA, Miller ML, Pejović V, Graham SM, Perhach JL.

J Alzheimers Dis. 2012;28(1):109-18. doi: 10.3233/JAD-2011-110947.

Improvement of the detection of neurodegenerative Alzheimer's disease through a specific surface chemistry applied onto the inner surface of the titration well

Mille C, Debarnot D, Zorzi W, El Moualij B, Coudreuse A, Legeay G, Quadrio I, Perret-Liaudet A, Poncin-Epaillard F.

J Biomater Sci Polym Ed. 2012;23(15):1951-61. doi: 10.1163/092050611X600712. Epub 2012 May 8.

CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial

Kurz A, Thöne-Otto A, Cramer B, Egert S, Frölich L, Gertz HJ, Kehl V, Wagenpfeil S, Werheid K.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):246-53. doi: 10.1097/WAD.0b013e318231e46e.

The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis

Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M.

J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217.

Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?

Moghbel MC, Saboury B, Basu S, Metzler SD, Torigian DA, Långström B, Alavi A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):202-8. doi: 10.1007/s00259-011-1960-4.

Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease

Ricci S, Fuso A, Ippoliti F, Businaro R.

J Alzheimers Dis. 2012;28(1):11-24. doi: 10.3233/JAD-2011-110821.

Could cholinesterase inhibitors be harmful over the long term?

Schneider LS.

Int Psychogeriatr. 2012 Feb;24(2):171-4. doi: 10.1017/S1041610211002389.

Chronic psychosocial stress exposes Alzheimer's disease phenotype in a novel at-risk model

Alkadhi KA.

Front Biosci (Elite Ed). 2012 Jan 1;4(1):214-29. doi: 10.2741/371.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias